Trial intelligence / Profile preview

Fortesta Gel 2% PK and Drying Time in Hypogonadism

NCT01228071Phase 3Completed

Sponsor
Endo International plc
Start
Nov 2010
Primary completion
May 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of AndroForte in Hypogonadism, sponsored by Endo International plc. Started Nov 2010; status: completed.

02

Drugs

AndroForte
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT01228071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01228071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call